US Stock Market Move | Cardigan (KARD.US) enters the US stock market, opening with a more than 25% increase.

date
00:00 19/06/2026
avatar
GMT Eight
Cardigan made its debut in the US stock market, with its stock price jumping over 25% at the opening, reaching $20.1.
On Thursday, Kardigan (KARD.US) made its debut on the US stock market, with its opening price increasing by over 25% to $20.1. The IPO price was $16. Kardigan is a clinical-stage biotechnology company focused on developing innovative therapies for cardiovascular diseases, aiming to create a new generation of precision drugs for treating arrhythmias and other heart diseases. The company's core product pipeline focuses on regulating cardiac electrophysiology, improving abnormal heart rhythm problems by targeting specific ion channels, with the goal of increasing efficacy while reducing the safety risks associated with traditional antiarrhythmic drugs. Currently, several of the company's candidate drugs are still in clinical development and have not generated commercial revenue yet.